Novel and emerging therapies for B cell lymphoma

Overview of attention for article published in Journal of Hematology & Oncology, July 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 6,701 followers.

RT @hematoclinicbcn: 📒Review: Novel and emerging therapies for B cell lymphoma. #OpenAcces #lymsm https://t.co/x63x9acKAO

📒Review: Novel and emerging therapies for B cell lymphoma. #OpenAcces #lymsm https://t.co/x63x9acKAO

RT @pb10_bmt: Antibody based and other small molecule novel therapies for B cell lymphoma. Increasing options for relapsed disease + would…

Antibody based and other small molecule novel therapies for B cell lymphoma. Increasing options for relapsed disease + would be interesting to see how they fit in with autoSCT. https://t.co/KJPJcRiZd3 @BioMedCentral https://t.co/4lUrbaghw9

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.